Jasmine Crockett Concealed Stock Investments in Pharmaceutical, Fossil Fuel, and Marijuana Firms
Rep. Jasmine Crockett (D-Texas), known for her left-leaning views, has reportedly maintained a hidden stock portfolio and has shown interest in the marijuana industry. In an article from the Washington Free Beacon, Andrew Carr shed light on Crockett’s questionable financial activities. The article indicated that Crockett owned stock in a minimum of 25 companies, which […]
Mikie Sherrill received over $25K from pharmaceutical companies linked to the opioid crisis, according to documents.
Mikie Sherrill, the Democratic candidate for governor in New Jersey, has accepted over $25,000 in campaign donations from a large pharmaceutical company implicated in the opioid crisis. This came to light during a crucial debate where her Republican opponent, Jack Ciatarelli, accused her of partaking in the same issue he claims she’s criticizing him for. […]
CF PharmTech, a Chinese pharmaceutical firm, jumps 224% in its trading debut in Hong Kong.
Market Update The median rent for a one-bedroom apartment in Hong Kong is projected to be $2,421 by 2025. On Wednesday, gold spot prices surged to $4,000 for the first time, driven by a strong demand for secure assets. According to Vivek Dahl, who leads the commodities sector at Australia’s Commonwealth Bank, this increase likely […]
Stocks Rise as Pharmaceutical and Chip Companies Gain Ground
Market Summary The S&P 500 index closed on Tuesday with a gain of 0.41%. The Dow Jones Industrial Average followed with a 0.18% increase, while the Nasdaq 100 also saw a rise of 0.28%. In the futures market, December e-mini S&P futures rose by 0.39%, and December e-mini Nasdaq futures increased by 0.26%. After experiencing […]
Website to provide discounted medications through major pharmaceutical agreement
Trump’s New Contract Aims to Reform Drug Pricing President Donald Trump has unveiled a significant new contract aimed at reforming the pharmaceutical industry and reducing drug prices for consumers. He mentioned a substantial discount for Pfizer on some of its “most popular drugs,” and stated that all new drugs launched in the U.S. will be […]
Ex-congresswoman offers guidance on pharmaceutical strategy related to Abraham Accords
Kathy McMorris Rogers on Middle East Leadership Role Kathy McMorris Rogers is continuing her focus on Middle Eastern affairs even after her time in Congress. She recently discussed her new role with the American Israel Education Association (USIEA), where she aims to enhance leadership within the pharmaceutical sector. “As someone who has served in Congress, […]
Health groups challenging Trump’s claims about Tylenol and autism are closely aligned with pharmaceutical companies.
Health Groups Challenge Autism Claims by Trump Administration Health organizations have voiced strong disapproval of the Trump administration’s recent stance on autism, bringing attention to the potential implications from a healthcare viewpoint. However, it’s interesting to note that many of these groups have close connections with pharmaceutical companies. President Donald Trump and Health Secretary Robert […]
Harvard dean referenced in Trump’s Tylenol alert was a paid expert witness in 2023 lawsuit against the pharmaceutical company.
Research from Harvard that looks into the impact of Tylenol on pregnant women has surfaced amidst a warning from President Trump advising expectant mothers to steer clear of the drug. Dr. Andrea Bacarelli, the dean at Harvard’s T.H. Chan School of Public Health, recently co-authored a research review discussing acetaminophen, a common pain reliever, and […]
Pharmaceutical Company Introduces Medication at Identical Price in U.S. and Europe
Bristol Myers Squibb (BMS) announced on Monday that its new flagship drug will be available in international markets at the same price as in the US. The schizophrenia medication Cobenfy (Xanomeline and Trospium) is scheduled for a 2026 launch in the UK, priced equally to its US counterpart. Adam Lenkowsky, BMS’s Chief Commercialization Officer, stated: […]
PCOS overlooked as pharmaceutical companies gain from women’s infertility
Fertility Rates: A Growing Concern The drop in fertility rates has caught everyone’s attention for several understandable reasons. In the U.S., the fertility rate has fallen to 1.6 births per woman—well below the replacement level of 2.1. Earlier this year, the Trump administration suggested a plan to counteract this trend—a $5,000 single “baby bonus,” along […]